Skip to Content

Nano Curry

Encased curcumin could be a drug.
August 15, 2007

In recent years, laboratory and animal studies have suggested that curcumin–the pigment that gives the Indian curry spice turmeric its bright-yellow hue–could be useful for treating tumors, cystic fibrosis, and even Alzheimer’s disease. But curcumin is insoluble and not readily absorbed by the body, making it impractical as a drug.

The nanoparticles shown here have hydrophobic interiors that hold the curcumin and hydrophilic exteriors that make them more readily absorbed.

Now researchers at the Johns Hopkins University School of Medicine and the University of Delhi, in India, have invented ­curcumin-­carrying nanospheres that slip easily into the bloodstream. ­Anirban Maitra, an associate professor of pathology and oncology at Johns Hopkins, and his collaborators in Delhi used polymers to make particles about 50 nanometers in diameter. The nanoparticles (left) have hydrophobic interiors that hold the curcumin and hydrophilic exteriors that make them more readily absorbed. Once the particles are in the blood, the curcumin leaks out as the polymers slowly degrade. Maitra and colleagues are now planning animal studies.

Keep Reading

Most Popular

10 Breakthrough Technologies 2024

Every year, we look for promising technologies poised to have a real impact on the world. Here are the advances that we think matter most right now.

Scientists are finding signals of long covid in blood. They could lead to new treatments.

Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.

AI for everything: 10 Breakthrough Technologies 2024

Generative AI tools like ChatGPT reached mass adoption in record time, and reset the course of an entire industry.

What’s next for AI in 2024

Our writers look at the four hot trends to watch out for this year

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.